Arutimol 0, 5%

It refers to the group Arutimol antiglaucoma drugs, non-selective β-adrenoceptor blockers. Available in a 0, 25 and 0%, 5% eyedrops. The active ingredient of the drug - timolol.

Pharmacological action

Eyedrops Arutimol reduce intraocular pressure. The pharmacological effect of the drug is achieved by reducing and improving the outflow of aqueous humor secretion.

Eyedrops Arutimol intended for topical use, but due to the fact that the drug is absorbed through the mucosa of the eye membrane may overall effect is seen with β-adrenergic blockers.

The active ingredient of the drug timolol, reducing eye pressure, no negative effect on pupil size and accommodation.

Indications Arutimola

According to the instructions Arutimolu, indications for use of the drug is:

- Chronic glaucoma;

- Ocular hypertension;

- Glaucoma when aphakia;

- Juvenile glaucoma in the absence of the effect of other treatments.

Dosing and Administration Arutimola

Eye drops Arutimol are water- and airtight flakonchike. Before the first use of the drug is necessary to rotate the cap clockwise to spike, which is in the middle, pierced dropper vial. Then return the cap to its original position (rotating in the opposite direction).

Eye drops Arutimol must be instilled into the conjunctival sac. To do this, tilt the head back and look up, pull the eyelid hand, gently press the bottle and drip drops on the conjunctiva. It should be remembered that the edge of the vial should not come into contact with the eye. After instillation you need to press the inner corner of the eye, to avoid getting the drug in the tear duct and its spread throughout the body.

 Arutimol 0, 25%
 According to the instructions Arutimolu, drug treatment long enough. Dose reduction or treatment is possible only after prior doctor appointments.

The dose for adults and children is one drop of 0, 25% solution twice a day to the affected eye. After sustained pressure reducing eye drops Arutimol continue to bury one drop per day.

If the treatment is not a desired effect, then a transition to 0, 5% drop Arutimola.

Contraindications Arutimola

- Hypersensitivity to timolol;

- Bronchial hyperreactivity;

- bronchial asthma;

- Chronic obstructive pulmonary disease, severe;

- heart failure;

- Bradycardia;

- Allergic rhinitis;

- Cardiogenic shock;

- The defeat of the cornea dystrophic.

Side effects after applying Arutimola

The instructions to Arutimolu listed side effects:

- Organs of vision: blurred vision, dryness of the eye, keratitis, blepharitis, conjunctivitis;

- Respiratory tract: in patients with bronchial asthma may develop bronchospasm and shortness of breath;

- Skin: rash, urticaria;

- Heart and blood vessels: in patients with diseases of the cardiovascular system may develop stroke, arrhythmia, cerebral ischemia, syncope, heart failure, tachycardia, bradycardia.

- The central nervous system: nausea, weakness, depression, dizziness, headache.

Common side effects of the drug are more common in children.

Further instructions

When treating Arutimolom should monitor the intraocular pressure and regularly examine the cornea.

With caution should be used when eye drops Arutimol poor circulation in the brain. If there is a decrease in cerebral blood flow, you must stop using the product and seek other treatment.

Excipient benzalkonium chloride, which is in the drops, may cause eye irritation. As a consequence of the drug should be avoided with contact lenses. Before applying Arutimola contact lenses should be removed and put them 15 minutes after instillation.

Use of the drug during pregnancy and breastfeeding

According to the instructions, Arutimol is contraindicated during pregnancy and lactation. Appointment Arutimola before birth can cause hypoglycemia (decrease in blood sugar levels), bradycardia (reduced heart rate), neonatal asphyxia (respiratory depression in the neonate).

During treatment should avoid working with dangerous machinery and driving vehicles.

storage conditions

Bottle of eye drops Arutimol should be stored in a dark place at a temperature of 25 degrees. Opened vials should be used no more than six weeks.